Journal News

Re-creating coagulation in a lab

A positive step for the horseshoe crab
Kian Kamgar-Parsi
Sept. 15, 2020

When considering modern medicine’s fight against infections, a horseshoe crab is likely not the first thing that comes to mind. However, the dwindling number of these ancient arthropods is cause for concern in the biomedical industry.

Kaldari/Wikimedia Commons
The horseshoe crab has been around for 450 million years and is more closely related to spiders than other crabs. Use of horseshoe crabs’ blue blood (called hemolymph) for medical tests threatens a species already pressured by environmental change and human development.

Bacterial lipopolysaccharide, or LPS, is a toxic molecule that can cause life-threatening infectious reactions in humans. Horseshoe crab hemolymph (a blood equivalent) is extremely sensitive to LPS, coagulating in response to even trace amounts. Due to this property, hemolymph is used in the Limulus test, a critical tool to ensure medical devices and drugs are free of LPS contamination. Unfortunately, the harvesting of hemolymph pits medical and conservation interests against each other.

Shun-Ichiro Kawabata, a researcher at Kyushu University in Japan, seeks a solution to this conflict. “(The) raw materials of Limulus test are totally dependent on the limited natural resource,” he said. “As an alternative approach, we have been doing studies to develop a next-generation Limulus test using recombinant (engineered) proteins.”

Recent research published by Kawabata and his colleagues in the Journal of Biological Chemistry represents an important step toward a hemolymph-free Limulus test.

In their study, Kawabata’s team focused on the main catalytic pathway of hemolymph coagulation: three zymogens (inactive enzyme precursors) called proC, proB and proCE. In the presence of LPS, proC is activated into an enzyme called alpha-chelicerase C that converts proB into chelicerase B; chelicerase B in turn activates proCE into the clotting enzyme that coagulates the hemolymph. Kawabata previously engineered functional proC and proB; in this new research, his lab also made a functional proCE without the use of hemolymph for the first time.

“We have overcome several difficulties in preparing these recombinant proteins, and now we have (all) three recombinants: proC, proB, and proCE,” Kawabata said. Using these three proteins to reconstitute the coagulation cascade, the team discovered that specific regions and amino acids in proB and proCE are key for activation. Now they are using their set of recombinant zymogens and these recent data to improve on nature’s designs.

“We are pushing this work forward to prepare more effective and stable recombinants of the protease zymogens applicable for the detection of LPS,” Kawabata said.

Challenges remain before a fully synthetic hemolymph substitute can be used for the Limulus test. While the proteins developed by the team represent the core components, three proteins alone cannot mimic hemolymph perfectly. “Some cofactors, environmental proteins or some preservatives must be indispensable,” Kawabata said.

It is also important to ensure that the cascade cannot be triggered by other environmental substances, something that will require further testing and optimization.

Although questions remain, Kawabata and his team already are working with companies in Japan “to make a more sensitive and convenient test … and ensure a continuous supply of the best materials,” he said.

In time, the proteins developed in the Kawabata lab could bring medical and conservation concerns into harmony, protecting the horseshoe crab population while providing a powerful tool to prevent infections.

Kian Kamgar-Parsi

Kian Kamgar-Parsi received a Ph.D. in biophysics from the University of Michigan and works as a consultant for the pharmaceutical industry.
 

Related articles

Reimagining STEM workforce development as a braided river
Rebecca L. Batchelor, Hendratta Ali, Kathryn G. Gardner-Vandy, Anne U. Gold, Jennifer A. MacKinnon & Pranoti M. Asher

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

St. Jude and maximizing the value of blood
Health Observance

St. Jude and maximizing the value of blood

June 14, 2021

The hospital is most renowned for passing along no costs to families. To facilitate this, the in-house capabilities of St. Jude are second to none. This includes the on-site blood donation facilities.

A balancing game with implications for neurodegenerative disease
Journal News

A balancing game with implications for neurodegenerative disease

June 8, 2021

The relationship between two proteins, one essential to mitochondrial fission and the other found in Alzheimer’s tissue, might hold the key to how disease alters the fission–fusion balance.

Can people vaccinated against COVID-19 still spread the coronavirus?
News

Can people vaccinated against COVID-19 still spread the coronavirus?

June 6, 2021

Preliminary evidence seems to suggest that someone who’s vaccinated is less likely transmit the virus, but the proof is not yet ironclad.

Addgene expands its collection into antibodies
News

Addgene expands its collection into antibodies

June 4, 2021

The reagent repository Addgene, known for distribution and quality control of plasmids for open science, is expanding into recombinant antibodies and nanobodies in partnership with NeuroMab.

Study reveals experimental targets for lymphoma research
Journal News

Study reveals experimental targets for lymphoma research

June 3, 2021

An enzyme previously linked to lymphoma development may have more functions than previously thought.

Exploring underappreciated molecules and new cities
Interview

Exploring underappreciated molecules and new cities

June 2, 2021

Neurochemist Xianlin Han has been an associate editor for the Journal of Lipid Research since 2019.